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Some studies have reported a decrease in the natural killer (NK) cell activity in smokers. However, large-scale data on the relation-
ship between NK cell activity and smoking are unavailable. A cross-sectional study was performed on 12,249 asymptomatic exam-
inees who underwent an NK cell activity test, between January 2016 and May 2017. The test quantitated the amount of interferon-γ 
secreted into the plasma by NK cells, using a patented stimulatory cytokine. The mean age of the study population was 39.1 years, 
and the proportions of “never”, “former”, and “current” smokers were 65.5%, 20.9%, and 13.6%, respectively. Current smokers (1,422 
pg/mL) had a lower median level of NK cell activity than never smokers (1,504 pg/mL, P = 0.039) and former smokers (1,791 pg/
mL, P < 0.001). Among current smokers, NK cell activity decreased with increase in the number of cigarettes smoked among cur-
rent smokers (median, 1,537, 1,429, and 1,175 pg/mL at <10, 10-19, and ≥ 20 pack-years, respectively; P < 0.001). Additionally, it 
decreased linearly with increasing quartiles of cotinine levels (median, 1,707, 1,636, 1,348, and 1,292 pg/mL at cotinine levels < 292, 
292-879, 880-1,509, and ≥ 1,510 ng/mL, respectively; r = –0.122, P < 0.001). NK cell activity was lower in current smokers. It also 
decreased with an increase in the number of cigarettes smoked, and it was negatively correlated with cotinine levels among current 
smokers. Our findings indicate a clear relationship between smoking and decreased NK cell activity.
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INTRODUCTION
The host immune system plays a critical role in the 
surveillance, detection, and elimination of aberrant cells 
[1,2]. Accordingly, the incidences of cancer and infection 
are increased in immune-compromised hosts [2]. Natural 
killer (NK) cells are large granular lymphocytes that play an 
important role in innate immunity, and are involved in the 
early defense against cancers and infections [1]. Several 
studies have reported that low NK cell activity is associated 
with an increased cancer risk, suggesting its role in the 
natural immunological host defense mechanisms against 
cancer [3-6].
 Cigarette smoke is a major health risk factor which 
increases the development of many types of cancer [7]. In 
a murine lung metastasis model, cigarette smoke impaired 
the NK cell-dependent tumor immune surveillance, and 
the altered immunity was associated with an increased 
tumor burden [8]. This study suggests that cigarette smoke 
compromises host immunity, enabling cancer cells to evade 
immune responses. Studies on humans have shown that NK 
cell activity is reduced in smokers [9-15]. Weakened NK cell 
activity and the consequent altered immune status in smokers 
may contribute to an increased cancer risk. However, 
in previously conducted studies which investigated the 
relationship between NK cell activity and smoking, in humans, 
the sample size was very low, at around 100 persons [9-15]. 
Moreover, most of those studies simply compared the NK 
cell activity between non-smokers and smokers; they did not 
evaluate NK cell activity, in detail, according to the number of 
cigarettes smoked. 
 Established methods that measure NK cell activity, such 
as the Chromium 51 (51Cr) release assay and CD107a 
degranulation assay, have been widely used to determine 
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NK cell function; however, these methods are complicated 
and time-consuming, because they require the isolation of 
the peripheral blood mononuclear cells (PBMC) or NK cells 
[16]. In addition, these assays sometimes require the use 
of hazardous materials such as radioactive isotopes [16]. 
Because of these difficulties in measuring NK cell activity, 
large-scale data on the relationship between NK cell activity 
and smoking in humans are currently unavailable.
 To overcome these difficulties, a simple assay that uses 
whole blood instead of PBMC or isolated NK cells was 
recently developed for commercial use, to measure the 
activity of NK cells (NK Vue® Kit; ATGen, Seongnam, Korea) 
[4,17]. This novel assay employs the serum of ex vivo 
stimulated whole blood to detect the IFN-γ secreted from the 
NK cells as an indicator of NK cell activity [4,17]. We aimed 
to evaluate the association of NK cell activity with the number 
of cigarettes smoked as well as smoking status, in a very 
large sample of asymptomatic examinees, using this novel 
and simple blood test. We also evaluated the relationship 
between NK cell activity and urinary cotinine level, an 
objective biomarker for tobacco exposure, to more clearly 
identify the association between NK cell activity and smoking.
MATERIALS AND METHODS
Study population
The Kangbuk Samsung Health Study is a cohort study of 
South Korean men and women, aged 18 years or older, 
who underwent a comprehensive annual or biennial health 
examination at the Kangbuk Samsung Hospital Total 
Healthcare Center in Seoul and Suwon, South Korea. 
The study population consisted of a subset of Kangbuk 
Samsung Health Study participants who underwent the NK 
cell activity test from January 2016 to May 2017. In South 
Korea, the Industrial Safety and Health Law requires annual 
or biennial health screening examinations of all employees, 
which are offered free of charge. Approximately 80% of the 
participants were employees of various companies and 
local governmental organizations, or their spouses, and 
the remaining participants volunteered for the screening 
examinations. 
 The exclusion criteria included having a history of cancer, 
inflammatory bowel disease, autoimmune disorders, 
known hepatitis B or C infections, and/or prescription use of 
immunosuppressive drugs, corticosteroids, and antibiotics 
within the last one month. Participants with missing data on 
smoking status were also excluded. 
 This study was approved by the Institutional Review Board 
(IRB) of Kangbuk Samsung Hospital, which exempted the 
requirement for informed consent because only de-identified 
data were accessed, retrospectively (IRB number: KBSMC 
2017-06-007). All methods were performed in accordance 
with the relevant guidelines and regulations.
Measurement and definition of variables 
Data on smoking status and comorbidities were collected 
through a self-administered questionnaire. Smoking habits 
were defined using the criteria of the National Health 
Interview Survey [18]. Participants who have smoked ≥ 
100 cigarettes in their life and continued smoking cigarettes 
were defined as “current smokers”. If the participants have 
smoked ≥ 100 cigarettes in their life, but did not smoke any 
longer, they were defined as “former smokers”. Participants 
who have never smoked a cigarette or have smoked < 100 
cigarettes in their life were defined as “never smokers”. The 
self-reported use of medication, on a regular basis over the 
last month, was also assessed. Obesity was defined as a 
body mass index ≥ 30 kg/m2, based on the criteria of the 
World Health Organization [19].
 Urinary cotinine levels were determined using the DRI 
Cotinine Assay (Microgenics Corp., Fremont, CA, USA) 
with the modular P800 analyzer (Roche Diagnostics, 
Tokyo, Japan). Cotinine-verified smokers were defined as 
participants having a urinary cotinine level ≥ 50 ng/mL [20].
 The presence or absence of fatty liver was examined 
through abdominal ultrasonography (US). A US diagnosis 
of fatty liver was made on the basis of four known criteria, 
namely: hepatorenal echogenic contrast, liver brightness, 
deep attenuation, and vascular blurring [21]. In our study, 
abdominal US was performed using a 3.5-MHz transducer 
(Logiq 9; General Electric, Madison, WI, USA), by 
experienced radiologists.
Natural killer cell activity measurement
NK cell activity was measured using a recently developed 
simple blood test (NK Vue® kit; ATGen). A 1-mL sample of 
whole blood, drawn using a direct vacutainer system from a 
new venipuncture point, was directly transferred into a tube 
specific to the NK cell activity test. The blood collection tube 
for the NK cell activity test contains a patented stimulatory 
cytokine (PromocaTM; ATGen). The collected tube was gently 
and repeatedly mixed. Within 30 minutes of collection, it was 
incubated for 20-24 hours in a 37°C chamber, according to 
the manufacturer’s recommendation. During the incubation 
period, the stimulatory cytokine causes the secretion of IFN-g 
into the plasma, predominantly by the NK cells, rather than 
by other innate or adaptive immune cells [17]. 
 Following incubation, the supernatant was collected and 
centrifuged at 3,000 ×g for 3 minutes. The supernatant was 
immediately loaded onto the ELISA plates. The IFN-g was 
quantitated with a designed ELISA, and the level of IFN-g 
was expressed in pg/mL. 
 Although the concentration of IFN-g indicates NK cell 
activity, it is difficult to assume that it is exactly the same as 
NK cell activity. However, we expressed the concentration of 
IFN-g as NK cell activity for convenience.
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Statistical analysis
Continuous variables were described as mean ± SD or 
median (interquartile range, IQR), and categorical variables 
were presented as frequencies and percentages. Baseline 
characteristics according to the smoking status were 
compared using one-way analysis of variance and chi-square 
test for continuous and categorical variables, respectively. 
The comparison of the NK cell activity levels, according 
to the clinical characteristics including smoking habits, 
was performed using the non-parametric Mann–Whitney 
U-test or Kruskal–Wallis test. Among current smokers, the 
comparison of the proportion of participants with low vs. 
high NK cell activity levels (< 500 pg/mL vs. ≥ 500 pg/mL), 
according to the number of cigarettes smoked and duration of 
smoking, was performed using univariable logistic regression 
analysis. Age and sex were adjusted using the multivariable 
logistic regression model. The association between NK cell 
activity level and urinary cotinine level was assessed using 
Spearman’s rank correlation coefficients (r) for nonparametric 
correlations. All reported P-values were two-tailed, and 
P-values < 0.05 were considered statistically significant. 
PASW Statistics ver. 18 software (IBM Corp., Armonk, NY, 
USA) was used for statistical analyses.
RESULTS
Baseline characteristics of the study population
We reviewed the medical records of 13,595 participants 
who had undergone the NK cell activity test. Of these, 
972 were excluded because of a history of cancer (n = 
488), inflammatory bowel disease (n = 68), autoimmune 
disorders (systemic lupus erythematosus, n = 6), hepatitis 
B infection (n = 394), and/or hepatitis C infection (n = 16). 
Additionally, 356 participants were excluded due to the use of 
immunosuppressive drugs (n = 25), corticosteroids (n = 28), 
and antibiotics (n = 303) within the last month. After excluding 
18 participants with missing data on smoking habits, 12,249 
participants were finally analyzed.
 The baseline clinical characteristics of the study population 
are shown in Table 1. The mean age of the study population 
was 39.1 ± 7.7 years, and the proportion of males was 
60.2%. The proportions of never smokers, former smokers, 
and current smokers were 65.5% (n = 8,028), 20.9% (n 
= 2,560), and 13.6% (n = 1,661), respectively, and the 
proportion of cotinine-verified smokers (cotinine ≥ 50 ng/mL) 
was 12.4% (n = 1,301). The mean age and the proportion of 
males, as well as the prevalence of obesity, hypertension, 
diabetes mellitus, dyslipidemia, and fatty liver were higher 
in former or current smokers than in never smokers. The 
proportions of cotinine-verified smokers (cotinine ≥ 50 ng/mL) 
among never, former, and current smokers were 0.6%, 5.0%, 
and 85.8%, respectively. 
Natural killer cell activity according to smoking 
status and clinical characteristics
The median level of NK cell activity (level of IFN-g) of all the 
participants was 1,546 pg/mL (IQR, 673–2,722 pg/mL). Table 
2 shows the median levels of NK cell activity, according to 
the clinical characteristics including smoking habits. Current 
smokers had lower NK cell activity than never smokers (1,422 
vs. 1,504 pg/mL, P = 0.039). Current smokers also had lower 
NK cell activity than former smokers (1,422 vs. 1,791 pg/mL, 
P < 0.001). However, former smokers had a rather higher 
level of NK cell activity than never smokers (1,791 vs. 1,504 
pg/mL, P < 0.001). Cotinine-verified smokers (cotinine ≥ 50 
ng/mL) had lower NK cell activity than cotinine-verified non-
smokers (cotinine < 50 ng/mL) (1,434 vs. 1,623 pg/mL, P < 
0.001). 
 The median level of NK cell activity was significantly lower 
in participants aged ≥ 40 years than in those aged < 40 
years (1,483 vs. 1,602 pg/mL, P < 0.001), and it was also 
lower in females than in males (1,318 vs. 1,724 pg/mL, P < 
0.001). There was no significant difference in the levels of 
NK cell activity between participants with and without obesity, 
Table 1. Baseline characteristics according to the smoking status 






(n = 1,661) P-value
Age (yr) 39.1 ± 7.7 37.8 ± 7.5 41.6 ± 7.7 41.2 ± 7.4 < 0.001
Male 7,371 (60.2) 3,337 (41.6) 2,431 (95.0) 1,603 (96.5) < 0.001
Obesity (BMI ≥ 30 kg/m2) 468 (3.8) 268 (3.3) 99 (3.9) 101 (6.1) < 0.001
Hypertension 882 (7.2) 383 (4.8) 329 (12.9) 170 (10.2) < 0.001
Diabetes mellitus 300 (2.4) 105 (1.3) 105 (4.1) 90 (5.4) < 0.001
Dyslipidemia 1,907 (15.6) 889 (11.1) 612 (23.9) 406 (24.4) < 0.001
Fatty liver 3,691 (30.1) 1,845 (23.0) 1,113 (43.5) 734 (44.2) < 0.001
Urinary cotinine (ng/mL)a
< 50 9,201 (87.6) 6,960 (99.4) 2,051 (95.0) 190 (14.2) < 0.001
≥ 50 1,301 (12.4) 45 (0.6) 108 (5.0) 1,148 (85.8)
Values are presented as mean ± SD or number (%). Baseline characteristics between groups were compared using one-way analysis of 
variance and chi-square test for continuous and categorical variables, respectively. BMI, body mass index. aThere are missing values in 
1,747 individuals.
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hypertension, diabetes mellitus, dyslipidemia, and fatty liver. 
Association between natural killer cell activity 
and the number of cigarettes smoked among 
current smokers 
To determine whether the number of cigarettes smoked 
influences NK cell activity, we compared the levels of NK 
cell activity, according to the number of cigarettes smoked 
and duration of smoking, among current smokers. Table 3 
shows that the median level of NK cell activity significantly 
decreased with increases in the number of cigarettes smoked 
and duration of cigarette smoking, among current smokers. 
Current smokers who smoked 20 or more cigarettes per day 
(median, 1,184 pg/mL; IQR, 487-2,064 pg/mL) had a lower 
NK cell activity than those who smoked 10-19 cigarettes 
per day (median, 1,468 pg/mL; IQR, 629-2,666 pg/mL; P < 
0.001), as well as those who smoked less than 10 cigarettes 
per day (median, 1,522 pg/mL; IQR, 728-2,734 pg/mL; P < 
0.001) (Fig. 1A). In addition, current smokers who had been 
smoking for 20 or more years had lower NK cell activity than 
those had been smoking for less than 20 years (median, 
1,334 vs. 1,514 pg/mL, P = 0.040). Current smokers with ≥ 
20 pack-years (median, 1,175 pg/mL; IQR, 534-2,109 pg/mL) 
had lower NK cell activity than those with 10-19 pack-years 
(median, 1,429 pg/mL; IQR, 560-2,664 pg/mL; P = 0.023), 
as well as those with < 10 pack-years (median, 1,537 pg/mL; 
IQR, 706-2,699 pg/mL; P < 0.001). Current smokers, with 10-
19 pack-years, also had lower NK cell activity than those with 
< 10 pack-years (P = 0.039) (Fig. 1B). 
 The manufacturer (ATGen) has set four intervals: low, 
borderline, concerned, and normal section, and presented 
the values of the percentiles 2.5% (100 pg/mL), 10% (250 
pg/mL), and 20% (500 pg/mL) as the cut-off values among 
these four intervals. In our cohort, the NK cell activity level 
at the 20th percentile was “540 pg/mL” and accordingly, we 
compared the number of cigarettes smoked and duration of 
smoking based on “500 pg/mL”, for convenience (Table 4). 
Among current smokers, those who smoked 10-19 cigarettes 
per day, as well as those who smoked 20 or more cigarettes 
per day, had lower NK cell activity level (< 500 pg/mL), 
compared to those who smoked less than 10 cigarettes per 
day (OR, 1.61; 95% CI, 1.14-2.27; P = 0.007 and 1.41; 1.04-
Table 2. Levels of NK cell activity according to the clinical 
characteristics 
Clinical characteristic NK cell activity (pg/mL) P-value
Smoking status (3 categories)
   Never smoker 1,504 (656-2,697) < 0.001
   Former smokers 1,791 (802-2,856)
   Current smokers 1,422 (623-2,592)
Smoking status (2 categories)
   Never or former smokers 1,572 (685-2,741) 0.001
   Current smokers 1,422 (623-2,592)
Urinary cotininea
   < 50 ng/mL 1,623 (716-2,802) < 0.001
   ≥ 50 ng/mL 1,434 (644-2,647)
Age (yr)
   < 40 (n = 6,797) 1,602 (706-2,776) < 0.001
   ≥ 40 (n = 5,452) 1,483 (640-2,656)
Sex
   Male 1,724 (761-2,815) < 0.001
   Female 1,318 (577-2,514)
Obesity 
   No (BMI < 30 kg/m2) 1,553 (678-2,724) 0.213
   Yes (BMI ≥ 30 kg/m2) 1,423 (600-2,680)
Hypertension
   No 1,546 (674-2,725) 0.663
   Yes 1,536 (658-2,692)
Diabetes mellitus
   No 1,552 (675-2,724) 0.168
   Yes 1,413 (603-2,631)
Dyslipidemia
   No 1,542 (672-2,720) 0.625
   Yes 1,575 (680-2,735)
Fatty liver 
   No 1,531 (661-2,717) 0.172
   Yes 1,572 (706-2,733)
Values are presented as median (interquartile range). The levels 
of NK cell activity were compared using the non-parametric 
Mann–Whitney U-test or Kruskal–Wallis test. NK, natural killer; 
BMI, body mass index. aThere are missing values in 1,747 
individuals.
Table 3. Levels of NK cell activity according to the number of 
cigarettes smoked and duration of smoking, among current 
smokers 
Smoking status NK cell activity (pg/mL) P-value
Daily number of cigarettes smoked 
   < 10 cigarettes/day (n = 457) 1,522 (728-2,734) < 0.001
   10-19 cigarettes/day (n = 874) 1,468 (629-2,666)
   ≥ 20 cigarettes/day (n = 330) 1,184 (487-2,064)
Duration of cigarette smoking
   < 20 years (n = 685) 1,514 (686-2,625) 0.040
   ≥ 20 years (n = 976) 1,334 (567-2,575)
Total number of cigarettes smoked
   < 10 pack-years (n = 738) 1,537 (706-2,699) < 0.001
   10-19 pack-years (n = 612) 1,429 (560-2,664)
   ≥ 20 pack-years (n = 311) 1,175 (534-2,109)
Urinary cotininea
   < 50 ng/mL (n = 190) 1,906 (857-2,875) 0.001
   ≥ 50 ng/mL (n = 1,148) 1,423 (629-2,601)
Urinary cotinineb
   < 292 ng/mL (n = 332) 1,707 (840-2,865) < 0.001
   292-879 ng/mL (n = 337) 1,636 (690-2,811)
   880-1,509 ng/mL (n = 334) 1,348 (590-2,593)
   ≥ 1,510 ng/mL (n = 335) 1,292 (534-2,235)
Values are presented as median (interquartile range). The levels 
of NK cell activity were compared using the non-parametric Mann–
Whitney U-test or Kruskal–Wallis test. NK, natural killer. aThere 
are missing values in 323 individuals. bValues were categorized 
into four groups by the quartiles of urinary cotinine levels.
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1.89; P = 0.025, respectively). In addition, current smokers 
with ≥ 10 pack-years had lower NK cell activity level (< 500 
pg/mL) than those with < 10 pack-years (OR, 1.46; 95% 
CI, 1.14-1.86; P = 0.003). After adjusting for age and sex, 
that showed a significant difference in NK cell activity, the 
associations between smoking amount (both daily and total) 
and NK cell activity remained significant. 
Association between natural killer cell activity 
and urinary cotinine levels among current 
smokers 
Current smokers with urinary cotinine levels ≥ 50 ng/mL 
had lower NK cell activity than those with urinary cotinine 
levels < 50 ng/mL (median, 1,423 vs. 1,906, P = 0.001). 
To identify the association between NK cell activity and 
urinary cotinine levels more clearly, the levels of NK cell 
activity were compared between four groups, by quartiles of 
urinary cotinine levels. The median levels of NK cell activity 
decreased linearly with increasing quartiles of urinary cotinine 
levels (1,707, 1,636, 1,348, and 1,292 pg/mL in current 
smokers, with urinary cotinine levels < 292, 292-879, 880-
1,509, and ≥ 1,510 ng/mL, respectively; P < 0.001) (Table 3). 
Figure 2 shows a significant negative correlation between the 
NK cell activity levels and quartiles of urinary cotinine levels 
(r = –0.122, P < 0.001). Urinary cotinine levels by themselves 
were also negatively correlated with NK cell activity (r = 
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Figure 1. Comparison of natural killer (NK) cell activity, according to the number of cigarettes smoked, among current smokers. (A) NK cell activity 
decreased with increases in the daily number of cigarettes smoked. (B) NK cell activity decreased with increases in the pack-years. The levels of NK 
cell activity between groups were compared using Mann–Whitney U-test.






analysisb P-value< 500 pg/mL 
(n = 339)
≥ 500 pg/mL 
(n = 1,322)
Daily number of cigarettes smoked 
   < 10 cigarettes/d 81 (17.7) 376 (82.3) 1 1
   10-19 cigarettes/d 173 (19.8) 701 (80.2) 1.61 (1.14-2.27) 0.007 1.67 (1.17-2.39) 0.005
   ≥ 20 cigarettes/d 85 (25.8) 245 (74.2) 1.41 (1.04-1.89) 0.025 1.36 (1.005-1.84) 0.046
Duration of cigarette smoking
   < 20 yr 124 (18.1) 561 (81.9) 1 1
   ≥ 20 yr 215 (22.0) 761 (78.0) 1.28 (0.999-1.64) 0.051 1.11 (0.80-1.54) 0.522
Total number of cigarettes smoked
   < 10 pack-years 126 (17.1) 612 (82.9) 1 1
   ≥ 10 pack-years 213 (23.1) 710 (76.9) 1.46 (1.14-1.86) 0.003 1.45 (1.10-1.92) 0.008
Urinary cotininea
   < 50 ng/mL 28 (14.7) 162 (85.3) 1 1
   ≥ 50 ng/mL 242 (21.1) 906 (79.8) 1.55 (1.01-2.37) 0.045 1.53 (0.998-2.34) 0.051
Values are presented as number (%) or OR (95% CI). NK, natural killer. aThere are missing values in 323 individuals. bValues were 
adjusted for age and sex.
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DISCUSSION 
In this large-scale study, including 12,249 asymptomatic 
participants, we found that current smokers had lower 
NK cell activity than never smokers and former smokers. 
Additionally, among current smokers, the level of NK cell 
activity decreased with increases in the number of cigarettes 
smoked, even after adjusting for age and sex. In addition, it 
was also negatively correlated with urinary cotinine levels. 
 Some animal studies have shown a decrease in NK cell 
activity under conditions of cigarette smoke exposure [8,22]. 
Spleen cells from animals subjected to a heavy dose of 
cigarette smoke exhibited a significant reduction in the NK 
cell-mediated lytic activity [22]. Another study revealed that 
cigarette smoke impairs NK cell-mediated tumor immune 
surveillance, and that altered immunity is associated with 
increased lung tumor burden in mice [8]. Several studies 
on humans have also reported that NK cell activity is more 
reduced in smokers than non-smokers [9-15,23]. However, a 
limitation of those previously conducted studies on humans is 
the very small sample size. With the exception of one study 
[23], the number of samples in all those studies ranged from 
54-119 participants [9-15]. 
 Several assays are available for the measurement of NK 
cell activity. Since 1968, the gold standard in the assessment 
of NK cell activity has been the 51Cr release assay, which 
is used to determine the cytolytic activity of effector cell 
populations [16]. However, the 51Cr release assay has many 
limitations, such as hazardous radioactivity, high cost, and 
short half-life of the isotopes [16]. Other established methods 
to assess NK cell activity, such as the CD107a degranulation 
assay and intracellular staining of IFN-g produced in NK cells, 
require the isolation of PBMC or NK cells from whole blood 
[24,25]. Furthermore, they require large amounts of whole 
blood to obtain enough PBMC or NK cells [24,25]. Due to the 
associated inconvenience and complexity, these methods 
have been used in research settings only. Accordingly, large-
scale data on the association between NK cell activity and 
smoking in humans are currently unavailable. 
 Using a simplified assay that uses whole blood, without the 
need to isolate of PBMC or NK cells, we could measure NK 
cell activity in a large sample of examinees. Like in the case 
of previously conducted studies’ results, our study showed 
that the NK cell activity was lower in current smokers than in 
never or former smokers. In addition, we found that NK cell 
activity decreased with increases in the number of cigarettes 
smoked, in a dose-response manner, among current 
smokers. Contrary to our study, most previously conducted 
studies simply compared NK cell activity between smokers 
and non-smokers. Our study is the first to evaluate NK 
cell activity, in detail, according to the number of cigarettes 
smoked. The higher degree of weakened NK cell activity and, 
consequently, altered immune status, may contribute to a 
higher risk of cancer in heavy smokers than light smokers. 
 In the present study, cotinine-verified smoking (cotinine ≥ 
50 ng/mL) was also associated with reduced NK cell activity. 
Participants with cotinine levels ≥ 50 ng/mL had lower NK 
cell activity than those with cotinine levels < 50 ng/mL, even 
among current smokers. Furthermore, NK cell activity was 
negatively correlated with cotinine levels. Given that cotinine 
is an objective biomarker for tobacco exposure, our results 
provide obvious evidence on the effect of smoking on NK cell 
activity. 
 Interestingly, former smokers had a rather higher level of 
NK cell activity than never smokers. One of the reasons may 
be that former smokers may have healthier lifestyles after 
quitting smoking. Our results are in accordance with those of 
an experimental study which showed that smoking cessation 
completely reversed the detrimental effects of cigarette 
smoke on tumor immune surveillance; this suggests that 
the impact of cigarette smoke on the NK cells is reversible 
[8]. Based on that study’s results and our own, smoking 
cessation may restore tumor immune surveillance. Our 
findings suggest that smoking cessation can reduce the risk 
of the development of smoking-related diseases. 
 We assessed NK cell activity according to other clinical 
characteristics, in addition to smoking status. NK cell 
activity was not different, depending on the presence of 
comorbidities including obesity, hypertension, diabetes 
mellitus, dyslipidemia, and fatty liver, whereas it was lower 
in older participants (≥ 40 years) than those aged < 40 
years, and it was also lower in women than in men. Like 
in the case of our results, a previously conducted study 
showed that older participants had lower NK cell activity than 
younger participants [26], and a recent study also pointed 
to an age-related reduction in NK cell activity [27]. Another 
study reported that NK cell activity was greater in men than 
in women [28]. NK cell activity may vary by age and sex. 
Further studies are needed to clarify if age and sex should be 
considered when determining the cut-off value of the NK cell 
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Figure 2. Correlation between natural killer (NK) cell activity levels and 
urinary cotinine levels. The correlation was assessed using Spearman’s 
rank correlation coefficients.
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activity test, for the detection of certain cancers. 
 To our knowledge, this is the largest study to identify the 
association between human NK cell activity and smoking. In 
addition, our study is the first to show a negative correlation 
between NK cell activity and cotinine. Nevertheless, the 
current study has several limitations. First, our study was not 
population-based, and included only ethnic Koreans. The 
interpretation of our findings requires careful consideration 
when applied to other populations. Second, most of the 
participants were employees of various companies and local 
governmental organizations, or their spouses; hence, there 
was a potential selection bias because most of them were 
likely to have a middle or upper class socio-economic status. 
Third, since most of the current smokers (96.5%) were men, 
the evaluation of the impact of smoking on NK cell activity in 
women was limited. Fourth, lifestyle factors such as mental 
stress and exercise, which may affect the levels of NK 
cell activity, were not considered. Fifth, the cross-sectional 
design precludes the determination of causality. In this study, 
longitudinal data were not collected, and hence we could not 
assess the changes of NK cell activities according to smoking 
status (such as smoking cessation). To more clearly elucidate 
the impact of smoking on NK cell activity, further longitudinal 
studies should be conducted. Finally, potential limitations of 
our study include its retrospective nature without measuring 
other cytokines, and we did not elaborate on the mechanism 
by which smoking affects NK cell activity.
 Despite these limitations, our data provide a better 
understanding of the effect of smoking on human NK cell 
activity. NK cell activity was lower in current smokers than in 
former or never smokers. It also decreased with increases 
in the number of cigarettes smoked, in a dose-response 
manner, among current smokers. Furthermore, it was 
negatively correlated with urinary cotinine levels. Our findings 
indicate a clear relationship between smoking and decreased 
NK cell activity.
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